Intranasal Diabetic Gastroparesis Tx OK'd; Tandem's Insulin Pump Now for Tots

(MedPage Today) -- The FDA approved Evoke Pharma's nasally administered diabetic gastroparesis treatment metoclopramide (Gimoti).
The American Society for Metabolic and Bariatric Surgery (ASMBS) is calling for the safe resumption of metabolic...

Source link

Related posts

Could Vitamin C Reduce Infant Harm From Smoking in Pregnancy?


CDC: Women in Poorest Regions Have Worst Birth Outcomes


Discovering how the brain works through computation


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy